Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors

被引：53

作者：

Zhang, Zhimin ^{[1
]}

Hou, Shaohua ^{[1
]}

Chen, Hongli ^{[1
]}

Ran, Ting ^{[2
]}

Jiang, Fei ^{[1
]}

Bian, Yuanyuan ^{[1
]}

Zhang, Dewei ^{[1
]}

Zhi, Yanle ^{[1
]}

Wang, Lu ^{[1
]}

Zhang, Li ^{[1
]}

Li, Hongmei ^{[1
]}

Zhang, Yanmin ^{[2
]}

Tang, Weifang ^{[1
]}

Lu, Tao ^{[2
,3
]}

Chen, Yadong ^{[2
]}

机构：

[1] Sch Sci, Dept Organ Chem, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China

[2] Sch Sci, Lab Mol Design & Drug Discovery, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China

[3] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tongjiaxiang, Nanjing 210009, Jiangsu, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2016年 / 26卷 / 12期

基金：

中国国家自然科学基金;

关键词：

Epigenetic; Protein-protein interactions; Bromodomain; HDAC; Antiproliferative activity; BROMODOMAIN; DISCOVERY;

D O I：

10.1016/j.bmcl.2016.04.034

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The bromodomain protein module and histone deacetylase ( HDAC), which recognize and remove acetylated lysine, respectively, have emerged as important epigenetic therapeutic targets in cancer treatments. Herein we presented a novel design approach for cancer drug development by combination of bromodomain and HDAC inhibitory activity in one molecule. The designed compounds were synthesized which showed inhibitory activity against bromodomain 4 and HDAC1. The representative dual bromodomain/HDAC inhibitors, compound 11 and 12, showed potent antiproliferative activities against human leukaemia cell line K562 and MV4-11 in cellular assays. This work may lay the foundation for developing dual bromodomain/HDAC inhibitors as potential anticancer therapeutics. (C) 2016 Elsevier Ltd. All rights reserved.

引用

页码：2931 / 2935

页数：5

共 50 条

[1] Synthesis and evaluation of novel dual BRD4/HDAC inhibitors
Amemiya, Seika
Yamaguchi, Takao
Hashimoto, Yuichi
Noguchi-Yachide, Tomomi
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (14) : 3677 - 3684
[2] Discovery of selective HDAC/BRD4 dual inhibitors as epigenetic probes
Chen, Jingjing
Li, Yalei
Zhang, Jie
Zhang, Minmin
Wei, Aihuan
Liu, Hongchun
Xie, Zhicheng
Ren, Wenming
Duan, Wenwen
Zhang, Zhuo
Shen, Aijun
Hu, Youhong
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 209
[3] Design, synthesis and biological evaluation of dihydroquinoxalinone derivatives as BRD4 inhibitors
Yang, Yifei
Zhao, Leilei
Xu, Bin
Yang, LingYun
Zhang, Jian
Zhang, Huibin
Zhou, Jinpei
[J]. BIOORGANIC CHEMISTRY, 2016, 68 : 236 - 244
[4] Design and synthesis of dual ALK/BRD4 inhibitors
Watts, Ellen
Tucker, Elizabeth
Heidenreich, David
Bellenie, Benjamin
Knapp, Stefan
Chesler, Louis
Hoelder, Swen
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
[5] Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents
Cheng, Gaoliang
Wang, Zhi
Yang, Jinyu
Bao, Yu
Xu, Qihao
Zhao, Linxiang
Liu, Dan
[J]. BIOORGANIC CHEMISTRY, 2019, 84 : 410 - 417
[6] Dual HDAC/BRD4 inhibitors against cancer
Omidkhah, Negar
Hadizadeh, Farzin
Ghodsi, Razieh
[J]. MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (10) : 1822 - 1836
[7] Dual HDAC/BRD4 inhibitors against cancer
Negar Omidkhah
Farzin Hadizadeh
Razieh Ghodsi
[J]. Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
[8] Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors
Shao, Mingfeng
He, Linhong
Zheng, Li
Huang, Lingxiao
Zhou, Yuanyuan
Wang, Taijing
Chen, Yong
Shen, Mingsheng
Wang, Fang
Yang, Zhuang
Chen, Lijuan
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (17) : 4051 - 4055
[9] Design, Synthesis, and in vitro Biological Evaluation of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors
Li, Xiangyang
Zhang, Jian
Zhao, Leilei
Yang, Yifei
Zhang, Huibin
Zhou, Jinpei
[J]. CHEMMEDCHEM, 2018, 13 (13) : 1363 - 1368
[10] Design, synthesis, and biological evaluation of quinoxalinone derivatives as potent BRD4 inhibitors
Xu, Kai-Yan
Wang, Xue-Ting
Cheng, Lei
Cui, Qi-Hang
Shi, Jian-Tao
Zhang, Li-Wen
Chen, Shi-Wu
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 78

← 1 2 3 4 5 →